Extended Research Article
Intravitreal ranibizumab versus aflibercept versus bevacizumab for macular oedema due to central retinal vein occlusion: the LEAVO non-inferiority three-arm RCT
Philip Hykin
,
A Toby Prevost
,
Sobha Sivaprasad
,
Joana C Vasconcelos
,
Caroline Murphy
,
Joanna Kelly
et al.
-
Journal:
Health Technology Assessment Volume: 25, Issue: 38
-
Published:
16 June 2021